EUCTR2012-005002-22-DE进行中（未招募）1 期
ACEMg mediated hearing preservation in cochlear implant patients receiving different electrode lengths
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. 18 years of age or older
- •2. No or little benefit of conventional hearing aid, defined as preoperative auditory speech understanding of less or equal 60% in Freiburger monosyllables at 65 dB SPL, best aided in the ear to be implanted
- •3. Residual hearing better or equal than 80 dB HL at 125 and 250 Hz and better or equal than 90 dB HL at 500 Hz in the ear to be implanted
- •4. Ability to understand the study procedures, possible risks and benefits, and to give informed consent
- •5. Informed Consent is signed
- •6. Patients must agree not to use daily multi-vitamins or other supplements during the course of the study, and beginning at least 48 hours prior to first intake of the study medication
- •7. Female patients =50 years of age at the day of inclusion who have been postmenopausal since at least 1 year
- •female patients who have a negative hCG serum pregnancy test and meet one or more of the following criteria:
- •- 6 weeks after surgical sterilization by bilateral tubal ligation or bilateral ovariectomy with or without hysterectomy
- •- Using proven oral, injected or implanted hormonal contraceptive methods
- •- Intrauterine Device (IUD) or intrauterine system (IUS)
- •- Barrier methods: condom or occlusive cap (diaphragm or cervical/vault caps) with spermicide (foam / gel / film / cream / suppository)
- •- Male sterilisation (if the absence of sperm in the ejaculate is documented. For female participants the vasectomized male partner should be the sole sexual partner for that subject)
- •- True abstinence (Periodic abstinence and interruptus are not acceptable methods of contraception)
- •- Only female sexual partners
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 177
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 123
排除标准
- •Key Exclusion Criteria:
- •1. Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array, as confirmed by medical examination and imaging (e.g. DVT)
- •2. Signs of retrocochlear or central origin to hearing impairment as confirmed by medical examination and imaging (e.g. DVT)
- •3. Medical or psychological conditions which contraindicate surgery (e.g. active middle ear infections, tympanic membrane perforation)
- •4. Pregnancy or lactation
- •5. Additional handicaps that would prevent participation in evaluations
- •6. Contraindications for ACEMg:
- •6.1 hepatopathy (transaminases or ?-GT >= 2 x ULN (Upper Limit of Normal))
- •6.2 severe renal insufficiency (Serum creatinine > 2 x
- •6.3 disposition to kidney stones
- •6.4 iron-storage disease (thalassemia, hemochromatosis, sideroblastic anaemia)
- •6.5 co-medication with vitamin K-antagonists
- •6.6 heavy smoking (= 20 cigarettes per day)
- •7. Current participation in any other clinical trial and/or participation in another clinical trial within 30 days before the study begins
研究者
相似试验
招募中
不适用
Hearing preservation in cochlear implantation surgeryDeafnessNL-OMON49726niversitair Medisch Centrum Utrecht48
招募中
不适用
Hearing preservation in cochlear implantation surgeryNL-OMON20714Advanced Bionics48
尚未招募
不适用
To study the remaining hearing capability of children after surgery to insert a hearing device in the ear.CTRI/2020/04/024686Jipmer Pondicherry
招募中
1 期
Electroacoustic Stimulation of Extracochlear Cochlea-Implant ElectrodesH83Other diseases of inner earDRKS00030994niversitätsspital Zürich30
招募中
不适用
Effective Stimulus to the Cochlea: Intra-Cochlear Pressure MeasurementH83.9H74.9Disease of inner ear, unspecifiedDisorder of middle ear and mastoid, unspecifiedDRKS00007665niversitätsSpital ZürichKlinik für Ohren-, Nasen-, Hals- und Gesichtschirurgie25